Dutch Firm I-Med Technology Secures Investment for 3D Imaging Advancements
Netherlands, Wednesday, 4 December 2024.
I-Med Technology has received significant funding from 819 Capital Partners and LIOF to advance its head-mounted 3D imaging systems, enhancing precision in medical and dental procedures.
Strategic Investment Fuels Medical Innovation
In a significant development announced on November 19, 2024, I-Med Technology B.V., based at the Brightlands Health Campus in Maastricht, has secured substantial funding from 819 Capital Partners and LIOF [1]. The investment comes at a crucial time for the company, which was founded in 2018 and has been pioneering advanced head-mounted 3D imaging systems for healthcare applications [1].
Revolutionary 3D Imaging Technology
The company’s Digital Head-mounted Microscope represents a significant advancement in surgical visualization, offering Full HD real-time 3D imaging capabilities [1]. According to Vincent Graham, CTO at I-Med, this technology addresses a critical challenge in traditional surgical procedures where clinicians must frequently shift focus between 2D imaging displays and the surgical field [1]. The system not only enhances precision but also provides a more seamless operating experience, with additional capabilities for mixed reality applications [1].
Educational and AI Integration Potential
Jaap Heukelom, CCO at i-Med Technology, highlights that the system extends beyond surgical applications, offering significant potential for medical training and education [1]. The platform is designed to support remote assistance capabilities and provides a foundation for artificial intelligence integration, which can assist both surgeons and dentists in their clinical practice [1].
Investment Impact and Future Growth
The investment comes from 819 Capital Partners’ Evergreen Fund I, which focuses on deep-tech and med-tech ventures, while LIOF’s contribution is through their Participation Fund, aimed at supporting innovative SMEs [1]. Willem van Esch, investment manager at LIOF, emphasizes that this support will help accelerate I-Med’s impact across the healthcare sector, making advanced imaging more accessible and transforming the future of medical procedures [1].